Potential role of bromelain in clinical and therapeutic applications

Vidhya Rathnavelu; Noorjahan Banu Alitheen; Subramaniam Sohila; Samikannu Kanagesan; Rajendran Ramesh

doi:10.3892/br.2016.720

journal article Jul 18, 2016

Potential role of bromelain in clinical and therapeutic applications

Vidhya Rathnavelu Noorjahan Banu Alitheen

Subramaniam Sohila Samikannu Kanagesan Rajendran Ramesh

Biomedical Reports Vol. 5 No. 3 pp. 283-288 · Spandidos Publications

View at Publisher Save 10.3892/br.2016.720

Topics

No keywords indexed for this article. Browse by subject →

References

107

[1]

Morton "Pineapple" Fruits of Warm Climates (1987)

[2]

Scopes Protein Purification: Principles and Practice (1982)

[3]

Arnon "Antibodies to papain. A selective fractionation according to inhibitory capacity" Biochemistry (1967) 10.1021/bi00864a041

[4]

Ota "Preparation and chemical properties of purified stem and fruit bromelains" Biochemistry (1964) 10.1021/bi00890a007

[5]

Murachi "Purification and physical characterization of stem bromelain" Biochemistry (1964) 10.1021/bi00889a009

[6]

Hale "Proteinase activity and stability of natural bromelain preparations" Int Immunopharmacol (2005) 10.1016/j.intimp.2004.12.007

[7]

Devakate "Purification and drying of bromelain" Separ Purif Tech (2009) 10.1016/j.seppur.2008.09.012

[8]

Castell "Intestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intake" Am J Physiol (1997)

[9]

Maurer "Bromelain: Biochemistry, pharmacology and medical use" Cell Mol Life Sci (2001) 10.1007/pl00000936

[10]

Mialovyts'ka "Effect of phlogenzym in long-term treatment of patients with multiple sclerosis" Lik Sprava (2003)

[11]

White "Bioavailability of 125I bromelain after oral administration to rats" Biopharm Drug Dispos (1988) 10.1002/bod.2510090408

[12]

Taussig "Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application. An update" J Ethnopharmacol (1988) 10.1016/0378-8741(88)90127-4

[13]

Brien "Bromelain as a treatment for osteoarthritis: a review of clinical studies" Evid Based Complement Alternat Med (2004) 10.1093/ecam/neh035

[14]

Hale "Proteolytic activity and immunogenicity of oral bromelain within the gastrointestinal tract of mice" Int Immunopharmacol (2004) 10.1016/j.intimp.2003.12.010

[15]

Sarkar "Cell signaling pathways altered by natural chemopreventive agents" Mutat Res (2004) 10.1016/j.mrfmmm.2004.04.015

[16]

Huang "Bromelain inhibits lipopolysaccharide-induced cytokine production in human THP-1 monocytes via the removal of CD14" Immunol Invest (2008) 10.1080/08820130802083622

[17]

Bhui "Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway" Cancer Lett (2009) 10.1016/j.canlet.2009.03.003

[18]

Gaspani "In vivo and in vitro effects of bromelain on PGE(2) and SP concentrations in the inflammatory exudate in rats" Pharmacology (2002) 10.1159/000056191

[19]

Desser "Proteolytic enzymes and amylase induce cytokine production in human peripheral blood mononuclear cells in vitro" Cancer Biother (1994) 10.1089/cbr.1994.9.253

[20]

Engwerda "Bromelain activates murine macrophages and natural killer cells in vitro" Cell Immunol (2001) 10.1006/cimm.2001.1793

[21]

Engwerda "Bromelain modulates T cell and B cell immune responses in vitro and in vivo" Cell Immunol (2001) 10.1006/cimm.2001.1807

[22]

Barth "In vitro study on the immunological effect of bromelain and trypsin on mononuclear cells from humans" Eur J Med Res (2005)

[23]

Onken "Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro" Clin Immunol (2008) 10.1016/j.clim.2007.11.002

[24]

Hale "Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease" Clin Immunol (2005) 10.1016/j.clim.2005.04.011

[25]

Stopper "Genotoxicity of advanced glycation end products in mammalian cells" Cancer Lett (2003) 10.1016/s0304-3835(02)00626-2

[26]

Makrydimas "CD44 family and gynaecological cancer" In Vivo (2003)

[27]

Subramaniam "Soluble CD44 secretion contributes to the acquisition of aggressive tumor phenotype in human colon cancer cells" Exp Mol Pathol (2007) 10.1016/j.yexmp.2007.08.007

[28]

Massagué "TGFbeta in Cancer" Cell (2008) 10.1016/j.cell.2008.07.001

[29]

Bierie "Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer" Nat Rev Cancer (2006) 10.1038/nrc1926

[30]

Leipner "Therapy with proteolytic enzymes in rheumatic disorders" BioDrugs (2001) 10.2165/00063030-200115120-00001

[31]

Vellini "Possible involvement of eicosanoids in the pharmacological action of bromelain" Arzneimittelforschung (1986)

[32]

Inoue "Effect of etodolac on prostaglandin E2 biosynthesis, active oxygen generation and bradykinin formation" Prostaglandins Leukot Essent Fatty Acids (1994) 10.1016/0952-3278(94)90065-5

[33]

Oh-ishi "Bromelian, a thiolprotease from pineapple stem, depletes high molecular weight kininogen by activation of Hageman factor (Factor XIII)" Thromb Res (1979) 10.1016/0049-3848(79)90121-x

[34]

Seligman "Bromelain: An anti-inflammatory agent" Angiology (1962) 10.1177/000331976201301103

[35]

Giacca "Clinical experiences on the action of bromelin in peripheral venous diseases and in chronic bronchitic states" Minerva Med (1965)

[36]

Moss "Bromelains. The pharmacology of the enzymes" Arch Int Pharmacodyn Ther (1963)

[37]

De-Giuli "Bromelain, interaction with some protease inhibitor and rabbit specific antiserum" Drugs Exp Clin Res (1978)

[38]

Chobotova "Bromelain's activity and potential as an anti-cancer agent: current evidence and perspectives" Cancer Lett (2010) 10.1016/j.canlet.2009.08.001

[39]

Beuth "Modulation of murine tumor growth and colonization by bromelaine, an extract of the pineapple plant (Ananas comosum L.)" In Vivo (2005)

[40]

Báez "In vivo antitumoral activity of stem pineapple (Ananas comosus) bromelain" Planta Med (2007) 10.1055/s-2007-990221

[41]

Zavadova "Stimulation of reactive oxygen species production and cytotoxicity in human neutrophils in vitro and after oral administration of a polyenzyme preparation" Cancer Biother (1995) 10.1089/cbr.1995.10.147

[42]

Eckert "Effects of oral bromelain administration on the impaired immunocytotoxicity of mononuclear cells from mammary tumor patients" Oncol Rep (1999)

[43]

Snowden "Treatments for breast engorgement during lactation" Cochrane Database Syst Rev (2001)

[44]

Guimarães-Ferreira "Antitumor effects in vitro and in vivo and mechanisms of protection against melanoma B16F10-Nex2 cells by fastuosain, a cysteine proteinase from Bromelia fastuosa" Neoplasia (2007) 10.1593/neo.07427

[45]

Tysnes "Bromelain reversibly inhibits invasive properties of glioma cells" Neoplasia (2001) 10.1038/sj.neo.7900196

[46]

Mantovani "Cancer-related inflammation" Nature (2008) 10.1038/nature07205

[47]

Juhasz "Bromelain induces cardioprotection against ischemia-reperfusion injury through Akt/FOXO pathway in rat myocardium" Am J Physiol Heart Circ Physiol (2008) 10.1152/ajpheart.01005.2007

[48]

Ferris "NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma" Clin Cancer Res (2007) 10.1158/1078-0432.ccr-07-1544

[49]

Chen "Tumor promoting or tumor suppressing of NF-kappa B, a matter of cell context dependency" Int Rev Immunol (2008) 10.1080/08830180802130327

[50]

Hou "Cross-linked bromelain inhibits lipopolysaccharide-induced cytokine production involving cellular signaling suppression in rats" J Agric Food Chem (2006) 10.1021/jf052390k

Showing 50 of 107 references

Cited By

195

Osteoarthritis: Insights into Diagnosis, Pathophysiology, Therapeutic Avenues, and the Potential of Natural Extracts

Chiara Coppola, Marco Greco · 2024

Current Issues in Molecular Biology

Bromelain: a review of its mechanisms, pharmacological effects and potential applications

Virender Kumar, Bharti Mangla · 2023

Food & Function

Cytotoxic Effect of Bromelain on HepG2 Hepatocellular Carcinoma Cell Line

Sushma S. Murthy, T. Bala Narsaiah · 2021

Applied Biochemistry and Biotechnol...

Effectiveness of the integration of quercetin, turmeric, and N-acetylcysteine in reducing inflammation and pain associated with endometriosis. In-vitro and in-vivo studies

Mario Fadin, Maria C. Nicoletti · 2020

Minerva Ginecologica

The Potential of Phytochemicals in Oral Cancer Prevention and Therapy: A Review of the Evidence

Tzu-Ying Lee, Yu-Hsin Tseng · 2020

Biomolecules

Bromelain inhibits the ability of colorectal cancer cells to proliferate via activation of ROS production and autophagy

Tung-Cheng Chang, Po-Li Wei · 2019

PLoS ONE

Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications

F. SEMERARO, F. Morescalchi · 2019

Diabetes & Metabolism

Metrics

195

Citations

107

References

Details

Published: Jul 18, 2016
Vol/Issue: 5(3)
Pages: 283-288

Authors

V

Vidhya Rathnavelu

N

Noorjahan Banu Alitheen

Cite This Article

Vidhya Rathnavelu, Noorjahan Banu Alitheen, Subramaniam Sohila, et al. (2016). Potential role of bromelain in clinical and therapeutic applications. Biomedical Reports, 5(3), 283-288. https://doi.org/10.3892/br.2016.720

Potential role of bromelain in clinical and therapeutic applications

You May Also Like